In an interview to CNBC-TV18, Arvind Bothra, Religare Enterprises spoke about the recent developments varios pharma compnaies like the Strides Arcolab and Mylan deal and the warning letter which Jubilant Life Sciences got from the US FDA.
first published: Dec 5, 2013 04:04 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty snaps 4-day winning streak but rises 1% this week | Closing Bell
Live: Can Bihar poll outcome trigger Nifty to reclaim 26,000-mark? | Opening Bell
Live: Nifty holds above 25,900 but off nearly 100 pts from day's high | Closing Bell
Live: Will Nifty reclaim 26,000-mark amid record low inflation in Oct? | Opening Bell
